BACKGROUND: Coronavirus disease 2019 (Covid-19) might present neurological symptoms. We aimed to evaluate the frequency of them at the moment of emergency department (ED) visit and their impact in the prognosis. METHODS: Retrospective cohort study including all consecutive hospitalized cases between March 8th and April 11th, 2020. Covid-19 diagnosis was confirmed by polymerase chain reaction test and/or serology. We compared, in patients with and without neurological symptoms on admission, demographic, clinical presentation, and frequency and type of abnormal laboratory values. We analyzed the variables that were associated with in-hospital all-cause mortality by Cox-regression log-rank test. RESULTS: We included 576 hospitalized patients, 250 (43.3%) female, aged 67.2 years. At the moment of ED visit, 320 (55.6%) described neurological symptoms, including anosmia (146, 25.3%), myalgia (139, 24.1%), headache (137, 23.8%), and altered mental status (98, 17.0%). Neurological symptoms started the first symptomatic day in 198 (54.2%) cases. Patients with neurological symptoms presented later to the ED (7.9 versus. 6.6 days, p = .019). Only four (0.6%) cases had no typical Covid-19 general symptoms, and only six (1.9%) had a normal laboratory results, for a sensitivity of 98.7% (95% confidence interval (CI): 96.6%-99.6%) and 98.1% (95% CI: 95.7%-99.2%), respectively. In the multivariate Cox-regression of mortality predictors, anosmia (HR: 0.358, 95%CI: 0.140-0.916) and altered mental status (HR: 1.867, 95%CI: 1.162-3.001) were significant. CONCLUSION: Neurological symptoms were the most frequent extrapulmonary symptoms. They were present in half of the Covid-19 patients at the time of the ED visit. Anosmia on admission was an independent predictor of lower in-hospital mortality and altered mental status on admission predicted in-hospital mortality.
BACKGROUND: Coronavirus disease 2019 (Covid-19) might present neurological symptoms. We aimed to evaluate the frequency of them at the moment of emergency department (ED) visit and their impact in the prognosis. METHODS: Retrospective cohort study including all consecutive hospitalized cases between March 8th and April 11th, 2020. Covid-19 diagnosis was confirmed by polymerase chain reaction test and/or serology. We compared, in patients with and without neurological symptoms on admission, demographic, clinical presentation, and frequency and type of abnormal laboratory values. We analyzed the variables that were associated with in-hospital all-cause mortality by Cox-regression log-rank test. RESULTS: We included 576 hospitalized patients, 250 (43.3%) female, aged 67.2 years. At the moment of ED visit, 320 (55.6%) described neurological symptoms, including anosmia (146, 25.3%), myalgia (139, 24.1%), headache (137, 23.8%), and altered mental status (98, 17.0%). Neurological symptoms started the first symptomatic day in 198 (54.2%) cases. Patients with neurological symptoms presented later to the ED (7.9 versus. 6.6 days, p = .019). Only four (0.6%) cases had no typical Covid-19 general symptoms, and only six (1.9%) had a normal laboratory results, for a sensitivity of 98.7% (95% confidence interval (CI): 96.6%-99.6%) and 98.1% (95% CI: 95.7%-99.2%), respectively. In the multivariate Cox-regression of mortality predictors, anosmia (HR: 0.358, 95%CI: 0.140-0.916) and altered mental status (HR: 1.867, 95%CI: 1.162-3.001) were significant. CONCLUSION: Neurological symptoms were the most frequent extrapulmonary symptoms. They were present in half of the Covid-19 patients at the time of the ED visit. Anosmia on admission was an independent predictor of lower in-hospital mortality and altered mental status on admission predicted in-hospital mortality.
Authors: Javier Trigo; David García-Azorín; Álvaro Planchuelo-Gómez; Enrique Martínez-Pías; Blanca Talavera; Isabel Hernández-Pérez; Gonzalo Valle-Peñacoba; Paula Simón-Campo; Mercedes de Lera; Alba Chavarría-Miranda; Cristina López-Sanz; María Gutiérrez-Sánchez; Elena Martínez-Velasco; María Pedraza; Álvaro Sierra; Beatriz Gómez-Vicente; Juan Francisco Arenillas; Ángel L Guerrero Journal: J Headache Pain Date: 2020-07-29 Impact factor: 7.277
Authors: Joshua P Metlay; Grant W Waterer; Ann C Long; Antonio Anzueto; Jan Brozek; Kristina Crothers; Laura A Cooley; Nathan C Dean; Michael J Fine; Scott A Flanders; Marie R Griffin; Mark L Metersky; Daniel M Musher; Marcos I Restrepo; Cynthia G Whitney Journal: Am J Respir Crit Care Med Date: 2019-10-01 Impact factor: 21.405
Authors: Luigi Angelo Vaira; Giovanna Deiana; Alessandro Giuseppe Fois; Pietro Pirina; Giordano Madeddu; Andrea De Vito; Sergio Babudieri; Marzia Petrocelli; Antonello Serra; Francesco Bussu; Enrica Ligas; Giovanni Salzano; Giacomo De Riu Journal: Head Neck Date: 2020-04-29 Impact factor: 3.147
Authors: Adrian I Espiritu; Marie Charmaine C Sy; Veeda Michelle M Anlacan; Roland Dominic G Jamora Journal: J Neural Transm (Vienna) Date: 2021-08-27 Impact factor: 3.575
Authors: Carmen García-Sánchez; Marco Calabria; Nicholas Grunden; Catalina Pons; Juan Antonio Arroyo; Beatriz Gómez-Anson; Alberto Lleó; Daniel Alcolea; Roberto Belvís; Noemí Morollón; Isabel Mur; Virginia Pomar; Pere Domingo Journal: Brain Behav Date: 2022-02-08 Impact factor: 2.708
Authors: David García-Azorín; Javier Trigo; Enrique Martínez-Pías; Isabel Hernández-Pérez; Gonzalo Valle-Peñacoba; Blanca Talavera; Paula Simón-Campo; Mercedes de Lera; Alba Chavarría-Miranda; Cristina López-Sanz; María Gutiérrez-Sánchez; Elena Martínez-Velasco; María Pedraza; Álvaro Sierra; Beatriz Gómez-Vicente; Ángel Guerrero; Juan Francisco Arenillas Journal: Brain Behav Date: 2021-02-22 Impact factor: 3.405